RU2545755C1 - Method of acridonacetic acid encapsulation - Google Patents

Abstract

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to chemical-pharmaceutical industry and represents method of medication encapsulation of by method of sedimentation with non-solvent, which is characterised by the fact that as medication applied is acridonacetic acid, and as envelope sodium carboxymethylcellulose, which is precipitated from solution in hexane by addition as non-solvent of methanol and water at 25°C.

EFFECT: invention ensures simplification and acceleration of process of obtaining microcapsules, reduction of loss in obtaining microcapsules (increase of output by weight).

3 ex

Description

The invention relates to the field of encapsulation, in particular the production of microcapsules of acridonoacetic acid.

Previously known methods for producing microcapsules of drugs. So, in RF patent 2092155, IPC А61К 047/02, А61К 009/16, published on 10/10/1997, a method for microencapsulation of drugs based on the use of ultraviolet radiation was proposed.

The disadvantages of this method are the duration of the process and the use of ultraviolet radiation, which can affect the process of formation of microcapsules.

In the patent of the Russian Federation 2091071, IPC А61К 35/10, published September 27, 1997, a method for producing the preparation by dispersion in a ball mill with the production of microcapsules is proposed.

The disadvantage of this method is the use of a ball mill and the duration of the process.

In the patent of the Russian Federation 2101010, IPC А61К 9/52, А61К 9/50, А61К 9/22, А61К 9/20, А61К 31/19, published January 10, 1998, a chewing form of the drug with a taste masking having the properties of controlled release of the drug is proposed The preparation contains microcapsules with a size of 100-800 microns in diameter and consists of a pharmaceutical core with crystalline ibuprofen and a polymer coating, including a plasticizer, flexible enough to withstand chewing. The polymer coating is a methacrylic acid based copolymer.

The disadvantages of the invention: the use of a copolymer based on methacrylic acid, as these polymer coatings can cause cancerous tumors; complexity of execution; the duration of the process.

In the patent of the Russian Federation 2173140, IPC A61K 009/50, A61K 009/127, published September 10, 2001, a method for producing silicon organolipid microcapsules using a rotary-cavitation unit with high shear forces and powerful sonar acoustic and ultrasonic dispersion ranges is proposed.

The disadvantage of this method is the use of special equipment - a rotary-quittance installation, which has an ultrasonic effect, which affects the formation of microcapsules and can cause adverse reactions due to the fact that ultrasound destructively affects polymers of a protein nature, therefore, the proposed method is applicable when work with polymers of synthetic origin.

In RF patent 2359662, IPC A61K 009/56, A61J 003/07, B01J 013/02, A23L 001/00, published June 27, 2009, a method for producing microcapsules using spray cooling in a Niro spray cooling tower under the following conditions: air temperature inlet 10 ° C; outlet air temperature 28 ° C; spray drum rotation speed of 10,000 rpm. The microcapsules of the invention have improved stability and provide controlled and / or prolonged release of the active ingredient.

The disadvantages of the proposed method are the duration of the process and the use of special equipment, a set of certain conditions (air temperature at the inlet 10 ° C, air temperature at the outlet 28 ° C, rotation speed of the spray drum 10,000 rpm).

The closest method is the method proposed in RF patent 2134967, IPC A01N 53/00, A01N 25/28, published 08/27/1999, a solution of a mixture of natural lipids and pyrethroid insecticide in a weight ratio of 2-4: 1 in an organic solvent is dispersed in water , which leads to a simplification of the microencapsulation method.

The disadvantage of this method is dispersion in an aqueous medium, which makes the proposed method inapplicable for producing microcapsules of water-soluble preparations in water-soluble polymers.

The technical task is to simplify and accelerate the process of obtaining microcapsules, reducing losses when receiving microcapsules (increase in yield by mass).

The solution of the technical problem is achieved by the method of encapsulation of acridonoacetic acid, characterized in that sodium carboxymethyl cellulose is used as the shell of the microcapsules when they are obtained by the physicochemical precipitation with a non-solvent using two precipitators - methanol and hexane, the production process is carried out without special equipment.

A distinctive feature of the proposed method is the use of sodium carboxymethyl cellulose as the shell of microcapsules, acridonoacetic acid as their core, as well as the use of two precipitants - methanol and hexane.

The result of the proposed method is to obtain microcapsules of acridonoacetic acid in sodium carboxymethyl cellulose at 25 ° C for 20 minutes. The output of microcapsules is more than 90%.

EXAMPLE 1 Obtaining microcapsules of acridonoacetic acid with dissolution of the drug in dioxane, the ratio of core / polymer 1: 3

100 mg of acridonoacetic acid is dissolved in 1 ml of dioxane and the resulting mixture is dispersed into a suspension of sodium carboxymethyl cellulose in hexane containing the indicated 300 mg of polymer in the presence of 0.01 g of the preparation E472c with stirring at 1000 r / sec. Then pour 2 ml of methanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0.396 g of a white with a yellowish tinge of powder. The yield was 99%.

EXAMPLE 2 Obtaining microcapsules of acridonoacetic acid with dissolution of the drug in dimethyl sulfoxide (DMSO), the ratio of core / polymer 1: 3

100 mg of acridonoacetic acid is dissolved in 1 ml of DMSO and the resulting mixture is dispersed into a suspension of sodium carboxymethyl cellulose in hexane containing the indicated 300 mg of polymer in the presence of 0.01 g of the preparation E472c with stirring at 1000 rpm. Then pour 2 ml of methanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0.396 g of a white with a yellowish tinge of powder. The yield was 99%.

EXAMPLE 3 Obtaining microcapsules of acridonoacetic acid with dissolution of the drug in dimethylformamide (DMF), the ratio of core / polymer 1: 3

100 mg of acridonoacetic acid was dissolved in 1 ml of DMF and the resulting mixture was dispersed into a suspension of sodium carboxymethyl cellulose in hexane containing the indicated 300 mg of polymer in the presence of 0.01 g of the preparation E472c with stirring at 1000 rpm. Then pour 2 ml of methanol and 1 ml of distilled water. The resulting suspension is filtered and dried at room temperature.

Received 0.396 g of a white with a yellowish tinge of powder. The yield was 99%.

Microcapsules of acridonoacetic acid were obtained by the physicochemical method of precipitation with a non-solvent using two precipitants - methanol and hexane, which helps to increase the yield and accelerates the microencapsulation process. The process is simple to execute and lasts for 20 minutes, does not require special equipment.

The proposed technique is suitable for the veterinary industry due to minimal losses, speed, ease of obtaining and isolation of microcapsules.

Claims (1)

A method of encapsulating a drug with a non-solvent precipitation method, characterized in that acridonoacetic acid is used as a drug, and sodium carboxymethyl cellulose is used as a coating, which is precipitated from a solution in hexane by adding methanol and water as a solvent at 25 ° C.